Detalles de la búsqueda
1.
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial.
Lancet Oncol
; 18(5): 587-598, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373007
2.
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.
Ann Rheum Dis
; 78(1): 150-152, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30185415
3.
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.
J Immunother Cancer
; 7(1): 269, 2019 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31639039
4.
Anti-PD-L1/TGFßR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis.
Urol Oncol
; 36(3): 93.e1-93.e11, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29103968
5.
Regulatory T Cell Effect on CD8+ T Cell Responses to Human Herpesvirus 8 Infection and Development of Kaposi's Sarcoma.
AIDS Res Hum Retroviruses
; 33(7): 668-674, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28121161
6.
Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.
J Immunother Cancer
; 5: 20, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28239472
7.
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.
Clin Cancer Res
; 23(22): 6833-6845, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28855356
8.
A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses.
Clin Transl Immunology
; 5(5): e83, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27350882
9.
Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types.
J Circ Biomark
; 5: 5, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28936253
10.
Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.
Cancer Immunol Res
; 4(9): 755-65, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27485137
11.
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
Oncotarget
; 7(25): 37762-37772, 2016 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27192116
12.
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.
Cancer Immunol Res
; 2(11): 1090-102, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092771
13.
Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcoma.
mBio
; 5(5): e01277-14, 2014 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25182322
14.
Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men.
Cancer Epidemiol Biomarkers Prev
; 22(11): 2009-15, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23983237
15.
Professional antigen presenting cells in human herpesvirus 8 infection.
Front Immunol
; 3: 427, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23346088
16.
Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.
Clin Vaccine Immunol
; 17(10): 1507-16, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20719985
Resultados
1 -
16
de 16
1
Próxima >
>>